Point72 Asia (Singapore)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$186K Buy
24,076
+7,381
+44% +$57.6K 0.03% 319
2025
Q2
$145K Buy
16,695
+4,901
+42% +$35.5K 0.03% 405
2025
Q1
$93.9K Buy
11,794
+10,564
+859% +$107K 0.02% 426
2024
Q4
$11.2K Sell
1,230
-13,434
-92% -$130K ﹤0.01% 730
2024
Q3
$135K Buy
14,664
+7,773
+113% +$64.3K 0.03% 467
2024
Q2
$67.4K Buy
6,891
+4,549
+194% +$55.5K 0.01% 573
2024
Q1
$35.4K Buy
+2,342
New +$42.5K 0.01% 877

Other funds holding TDOC

Point72 Asia (Singapore)'s TDOC Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its Teladoc Health (TDOC) stake by 44% in Q3 2025, buying an estimated $57.6K and bringing the position to 24,076 shares worth $186K. The position accounts for 0.03% of the portfolio, ranked #319.

Point72 Asia (Singapore) first reported a position in TDOC in Q1 2024 and has held it in 7 quarters since. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Point72 Asia (Singapore) held 24,076 shares of Teladoc Health worth $186K as of Q3 2025.
  • Point72 Asia (Singapore) bought 7,381 Teladoc Health shares in Q3 2025, an estimated $57.6K.
  • Teladoc Health made up 0.03% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #319 holding.
  • Point72 Asia (Singapore) first reported a position in Teladoc Health in Q1 2024 and has held it in 7 quarters since.
  • 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.